Skip to main content

Evogene Ltd.

EVGN
Exchange
Nasdaq
Industry
Agricultural Chemicals
SEC CIK
0001574565

In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Evogene Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
13
−2 vs. Q1 2026
Shares held
282.1K
−248.5K (−46.8%) vs. Q1 2026
Total value
$120.0K
−$288.9K (−70.6%) vs. Q1 2026
New holders
3
2 more added
Sold out
5
4 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting EVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 13 institutions
Q1 2021: 46 institutionsQ2 2021: 44 institutionsQ3 2021: 39 institutionsQ4 2021: 43 institutionsQ1 2022: 38 institutionsQ2 2022: 29 institutionsQ3 2022: 26 institutionsQ4 2022: 31 institutionsQ1 2023: 27 institutionsQ2 2023: 28 institutionsQ3 2023: 35 institutionsQ4 2023: 33 institutionsQ1 2024: 29 institutionsQ2 2024: 28 institutionsQ3 2024: 14 institutionsQ4 2024: 15 institutionsQ1 2025: 16 institutionsQ2 2025: 16 institutionsQ3 2025: 14 institutionsQ4 2025: 18 institutionsQ1 2026: 15 institutionsQ2 2026: 13 institutions
Value heldQ2 2026: $120.0K
Q1 2021: $42.2MQ2 2021: $25.3MQ3 2021: $16.7MQ4 2021: $10.1MQ1 2022: $3.18MQ2 2022: $1.25MQ3 2022: $1.21MQ4 2022: $753.9KQ1 2023: $500.6KQ2 2023: $759.5KQ3 2023: $2.73MQ4 2023: $3.90MQ1 2024: $3.49MQ2 2024: $2.56MQ3 2024: $1.70MQ4 2024: $751.6KQ1 2025: $526.9KQ2 2025: $166.9KQ3 2025: $176.1KQ4 2025: $199.8KQ1 2026: $408.9KQ2 2026: $120.0K
Institutions holding EVGN and their total value by quarter
QuarterHoldersValue
Q2 202613$120.0K
Q1 202615$408.9K
Q4 202518$199.8K
Q3 202514$176.1K
Q2 202516$166.9K
Q1 202516$526.9K
Q4 202415$751.6K
Q3 202414$1.70M
Q2 202428$2.56M
Q1 202429$3.49M
Q4 202333$3.90M
Q3 202335$2.73M
Q2 202328$759.5K
Q1 202327$500.6K
Q4 202231$753.9K
Q3 202226$1.21M
Q2 202229$1.25M
Q1 202238$3.18M
Q4 202143$10.1M
Q3 202139$16.7M
Q2 202144$25.3M
Q1 202146$42.2M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Evogene Ltd.; share changes are against Q1 2026.

Institutions holding EVGN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
HRT Financial LP107,198$45.0K0.00%+107,198New
Susquehanna International Group, LLP80,078$33.9K0.00%+80,078New
Citadel Advisors LLC50,526$21.4K0.00%+50,526New
XTX Topco Ltd19,404$8.21K0.00%+6,683+52.5%Added
UBS Group AG10,790$4.74K0.00%+4,438+69.9%Added
Daytona Street Capital LLC9,253$4.65K0.00%−333−3.5%Reduced
BNP Paribas Arbitrage, SA2,830$1.24K0.00%−6,294−69.0%Reduced
Morgan Stanley1,285$5640.00%−2,566−66.6%Reduced
Federation des caisses Desjardins du Quebec500$2200.00%00.0%Unchanged
Advisor Group Holdings, Inc.100$440.00%00.0%Unchanged
SHP Wealth Management65$290.00%00.0%Unchanged
SBI Securities Co., Ltd.62$270.00%−10−13.9%Reduced
Royal Bank of Canada42$00.00%00.0%Unchanged
Armistice Capital, LLC0$00.00%−456,587−100.0%Sold out
Jane Street Group, LLC0$00.00%−18,500−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−12,465−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−505−100.0%Sold out
Tradewinds Capital Management, LLC0$00.00%−131−100.0%Sold out